Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
NVAX
NVAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVAX News
BioNTech Announces Earnings, But That's Not the Reason for the 17% Drop in Stock Price.
3h ago
Barron's
FDA Vaccine and Biotech Chief Resigns Amid Industry Criticism
3d ago
CNBC
Novavax Q4 2025 Financial Results Analysis
Feb 27 2026
Benzinga
Top Stock Picks: Satellite Communications Firm Poised for Growth
Feb 27 2026
NASDAQ.COM
Novavax Q4 Revenue Surges 67% Amid Strategic Shift
Feb 27 2026
stocktwits
Novavax to Participate in Upcoming Investor Conferences
Feb 26 2026
PRnewswire
Novavax to Participate in Upcoming Investor Conferences
Feb 26 2026
Newsfilter
Novavax Q4 2025 Earnings Call Highlights
Feb 26 2026
seekingalpha
Novavax Exceeds Expectations in 2025 Financial Results
Feb 26 2026
Benzinga
Novavax Executive Expresses Optimism About Moderna's Advancements in Flu Vaccine Development
Feb 26 2026
moomoo
Novavax Stock Rises 6% Following Increased 2026 Adjusted Revenue Forecast
Feb 26 2026
moomoo
Comparing Vaccine Value: Novavax vs. Pfizer
Feb 26 2026
seekingalpha
Novavax Exceeds Q4 2025 Revenue Forecasts with Profitability
Feb 26 2026
seekingalpha
Novavax Reports Significant Q4 Revenue Increase Driven by Partnerships
Feb 26 2026
stocktwits
Novavax Q4 Earnings Exceed Expectations
Feb 26 2026
seekingalpha
Stock Market Movers: Nvidia, Sandisk, Salesforce, C3.ai, IonQ, Nutanix, and Others
Feb 26 2026
Barron's
Show More News
